Article Contents ::
- 1 The Brand Name CADSINE Has Generic Salt :: Adenosine
- 2 CADSINE Is From Company Gland Ph. Priced :: Rs. 300
- 3 CADSINE have Adenosine is comes under Sub class Anti Arrhythmics of Main Class Cardiovascular System
- 4 Main Medicine Class:: Cardiovascular System Sub Medicine Class :: Anti Arrhythmics
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name CADSINE Has Generic Salt :: Adenosine
CADSINE Is From Company Gland Ph. Priced :: Rs. 300
CADSINE have Adenosine is comes under Sub class Anti Arrhythmics of Main Class Cardiovascular System
Main Medicine Class:: Cardiovascular System Sub Medicine Class :: Anti Arrhythmics
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| Adenosine | INJ | Rs. 300 | 2ML PFS |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 2ML PFS |
| CADSINE | Gland Ph. | 3MG/ML | 2ML PFS | Rs. 300 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From Gland Ph. :: CADSINE | Adenosine | Cardiovascular System | Anti Arrhythmics |
Indications for Drugs ::
Paroxysmal supraventricular tachycardia,Supraventricular tachycardia
Drug Dose ::
Intravenous Differential diagnosis of supraventricular tachycardias Adult: Initially, 3 mg by rapid IV inj into a central or large peripheral vein over 2 sec with cardiac monitoring; 6 mg may be given after 1-2 minutes if necessary, then 12 mg after a further 1-2 minutes. Avoid increments if high level AV block occurs at any particular dose. Child: Initially, 50-100 mcg/kg; if necessary, may increase dose by 50-100 mcg/kg increments at 1-2 minute intervals or until arrhythmia is controlled. Max dose: 300 mcg/kg. Paroxysmal supraventricular tachycardia Adult: Initially, 3 mg by rapid IV inj into a central or large peripheral vein over 2 sec with cardiac monitoring; 6 mg may be given after 1-2 minutes if necessary, then 12 mg after a further 1-2 minutes. Avoid increments if high level AV block occurs at any particular dose. Child: Initially, 50-100 mcg/kg; if necessary, may increase dose by 50-100 mcg/kg increments at 1-2 minute intervals or until arrhythmia is controlled. Max dose: 300 mcg/kg. Myocardial imaging Adult: 140 mcg/kg/minute by infusion for 6 minutes. Inject radionuclide 3 minute after infusion.
Contraindication ::
2nd or 3rd degree AV block and sick sinus syndrome (unless pacemaker fitted), asthma, hypersensitivity.
Drug Precautions ::
Pregnancy; heart transplant patients; patients on dipyridamole (lower initial dose of adenosine 0.5-1 mg); atrial fibrillation or flutter with accessory pathway (conduction along anomalous pathway may increase).
Drug Side Effects ::
Facial flushing, palpitations, chest pain, bradycardia, sweating, hypotension, dyspnoea, choking sensation, headache, lightheadedness, tingling, numbness, neck and back pain, nausea, metallic taste. ECG changes suggestive of rhythm disturbances.
Pregnancy category ::
3
Drug Mode of Action ::
Adenosine acts rapidly to slow down conduction through the AV node via the A1 receptors. It also mediates peripheral and coronary vasodilatation by stimulating the A2 receptors. Extremely short plasma half-life (<10 sec) permits dosage titration during IV use every 1-2 min and causes no concern of cumulative effect through repeated dosing. Drug Interactions ::
Adenosine effects antagonised by methylxanthines like caffeine, theophylline, etc. Concomitant carbamazepine may increase the risk of heart block. Potentially Fatal: Adenosine effects are potentiated by dipyridamole.
